Chatham Capital Group’s Cambrex Corporation CBM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-17,022
Closed -$1.01M 163
2019
Q3
$1.01M Buy
17,022
+60
+0.4% +$3.21K 0.26% 92
2019
Q2
$794K Sell
16,962
-494
-3% -$20.7K 0.2% 104
2019
Q1
$678K Buy
17,456
+137
+0.8% +$5.61K 0.17% 110
2018
Q4
$654K Buy
17,319
+2,569
+17% +$130K 0.18% 101
2018
Q3
$1.01M Sell
14,750
-500
-3% -$30.9K 0.25% 86
2018
Q2
$798K Buy
15,250
+325
+2% +$16.2K 0.21% 91
2018
Q1
$781K Sell
14,925
-1,175
-7% -$62.8K 0.21% 89
2017
Q4
$773K Buy
16,100
+450
+3% +$22.3K 0.21% 88
2017
Q3
$861K Hold
15,650
0.24% 86
2017
Q2
$935K Buy
15,650
+1,150
+8% +$64.6K 0.26% 82
2017
Q1
$798K Buy
+14,500
New +$774K 0.22% 91

Other funds holding CBM

Chatham Capital Group's CBM Position: Q4 2019 in Review

Chatham Capital Group sold out of Cambrex Corporation (CBM) in Q4 2019, closing a stake of 17,022 shares — an estimated $1.01M sold.

Chatham Capital Group first reported a position in CBM in Q1 2017 and held it in 11 quarters. The position peaked at $1.01M in Q3 2019. 1 fund tracked by Wall St. Rank holds CBM as of Q4 2019.

  • Chatham Capital Group reported no remaining Cambrex Corporation position as of Q4 2019 after selling out during the quarter.
  • Chatham Capital Group sold 17,022 Cambrex Corporation shares in Q4 2019, an estimated $1.01M.
  • Chatham Capital Group first reported a position in Cambrex Corporation in Q1 2017 and held it in 11 quarters.
  • Chatham Capital Group's Cambrex Corporation position peaked at $1.01M in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Cambrex Corporation as of Q4 2019.

Based on Chatham Capital Group's 13F filing for Q4 2019, filed 31 Jan 2020.